These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15285638)

  • 1. [The features of atypical neuroleptic amisulpride action].
    Grigor'eva EA; Ritskov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
    [No Abstract]   [Full Text] [Related]  

  • 2. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ
    Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of amisulpride in short- and long-term use.
    Rein W; Coulouvrat C; Dondey-Nouvel L
    Acta Psychiatr Scand Suppl; 2000; 400():23-7. PubMed ID: 10823308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical advantages of amisulpride in the treatment of acute schizophrenia.
    Burns T; Bale R
    J Int Med Res; 2001; 29(6):451-66. PubMed ID: 11803729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.
    Peuskens J; Möller HJ; Puech A
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):305-10. PubMed ID: 12126869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 7. EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol.
    Pogarell O; Juckel G; Mulert C; Amann B; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 Nov; 37(6):304-5. PubMed ID: 15551199
    [No Abstract]   [Full Text] [Related]  

  • 8. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
    Kim SW; Shin IS; Kim JM; Yang SJ; Hwang MY; Yoon JS
    J Clin Psychopharmacol; 2008 Jun; 28(3):349-52. PubMed ID: 18480697
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on amisulpride.
    Green B
    Curr Med Res Opin; 2002; 18(3):113-7. PubMed ID: 12094819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of positive and negative symptoms: pharmacologic approaches.
    Boyer P; Lecrubier Y; Puech AJ
    Mod Probl Pharmacopsychiatry; 1990; 24():152-74. PubMed ID: 1970852
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation with amisulpride for schizophrenic patients non-responsive to risperidone monotherapy.
    Toledo-Romero F; Molina JD; López-Rodríguez E; Amorin-Díaz M; Muñoz Algar MJ; Aparicio-Castro E
    Pharmacopsychiatry; 2015 Mar; 48(2):51-7. PubMed ID: 25402816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on amisulpride in schizophrenia.
    Curran MP; Perry CM
    CNS Drugs; 2002; 16(3):207-11. PubMed ID: 11888341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia.
    Liang Y; Su YA; Zhao ZG; Gao N; Huang JZ; Tang MQ; Li KQ; Yang FD; Yu X; Si TM
    J Clin Psychopharmacol; 2015 Oct; 35(5):583-6. PubMed ID: 26270200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
    Linden M; Eich FX; Pyrkosch L
    Int Clin Psychopharmacol; 2007 May; 22(3):175-8. PubMed ID: 17414744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amisulpride, and atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. The Amisulpride Study Group.
    Puech A; Fleurot O; Rein W
    Acta Psychiatr Scand; 1998 Jul; 98(1):65-72. PubMed ID: 9696517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of amisulpride (Solian): a review of 11 clinical studies.
    Coulouvrat C; Dondey-Nouvel L
    Int Clin Psychopharmacol; 1999 Jul; 14(4):209-18. PubMed ID: 10468313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
    Müller MJ; Wetzel H; Eich FX; Rein W; Puech A; Benkert O;
    J Clin Psychopharmacol; 2002 Dec; 22(6):554-60. PubMed ID: 12454554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An importance of dose in antipsychotic combination therapy for schizophrenia.
    Suzuki T
    J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.